Exploring the Use of Medical Marijuana for Supportive Care of Oncology Patients
Authors:
- Msn Deena Damsky DellMDMsn Deena Damsky Dell
- Daniel P. SteinDSDaniel P. Stein
Open Access
- 1 March 2021
- journal article
- research article
- Published by Harborside Press, LLC in Journal of the Advanced Practitioner in Oncology
- Vol. 12 (2) , 188-201
Abstract
Medical marijuana, also known as cannabis, is being sought by patients and survivors to alleviate common symptoms of cancer and its treatments that affect their quality of life. The National Academy of Sciences (2017) reports conclusive or substantial evidence that cannabis is successful in treating chronic cancer pain and chemotherapy-induced nausea and vomiting, moderate evidence that cannabinoids are beneficial for sleep disorders that accompany chronic illnesses, and limited evidence supporting use for appetite stimulation and anxiety. However, due to the fact that cannabis is classified as a Schedule I controlled substance, there is an absence of rigorous, scientific evidence to guide health-care professionals. In addition, the Schedule I designation makes it illegal for health-care professionals in the United States to prescribe, administer, or directly distribute these drugs. Legislation has outpaced research in this area. Therefore, the National Council of State Boards of Nursing (NCSBN) appointed a medical marijuana guideline committee to create guidelines for the nursing care of patients using medical marijuana, marijuana education in nursing programs, and guidelines for advanced practice registered nurses (APRNs) certifying a patient for the use of medical marijuana (The NCSBN Medical Marijuana Guidelines Committee, 2018). Six states/districts authorize APRNs to recommend the use of medical marijuana to patients with qualifying conditions (Kaplan, 2015). As of March 2021, 35 states plus the District of Columbia have authorized the use of medical marijuana (DISA Global Solutions, 2021). Therefore, APRNs will be caring for these patients and need to know the medical, pharmacological, and legal issues surrounding medical cannabis use.Keywords
This publication has 14 references indexed in Scilit:
- Documentation of medical marijuana use in cancer patientsJournal of Oncology Pharmacy Practice, 2019
- Association Between Marijuana Use and Risk of CancerJAMA Network Open, 2019
- Medical Cannabis Use in Glioma Patients Treated at a Comprehensive Cancer Center in FloridaJournal of Palliative Medicine, 2019
- Impact of Medical Cannabis on Patient-Reported Symptoms for Patients With Cancer Enrolled in Minnesota’s Medical Cannabis ProgramJournal of Oncology Practice, 2019
- Prospective analysis of safety and efficacy of medical cannabis in large unselected population of patients with cancerEuropean Journal of Internal Medicine, 2018
- Medicinal Cannabis: History, Pharmacology, And Implications for the Acute Care Setting.2017
- Cannabinoids for Symptom Management and Cancer Therapy: The EvidenceJournal of the National Comprehensive Cancer Network, 2016
- Cannabinoid–Opioid Interaction in Chronic PainClinical Pharmacology & Therapeutics, 2011
- Cannabinoids for Cancer Treatment: Progress and PromiseCancer Research, 2008
- Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory actionTrends in Neurosciences, 1998